Vulvar cancer laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Human papilloma virus]] may be reported positive<ref name="pmid24505474">{{cite journal |vauthors=Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK |title=Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance |journal=PLoS ONE |volume=9 |issue=2 |pages=e88323 |date=2014 |pmid=24505474 |pmc=3914976 |doi=10.1371/journal.pone.0088323 |url=}}</ref>. | [[Human papilloma virus]] may be reported positive<ref name="pmid24505474">{{cite journal |vauthors=Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK |title=Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance |journal=PLoS ONE |volume=9 |issue=2 |pages=e88323 |date=2014 |pmid=24505474 |pmc=3914976 |doi=10.1371/journal.pone.0088323 |url=}}</ref>. | ||
Revision as of 14:08, 22 May 2019
Human papilloma virus may be reported positive[1].
References
- ↑ Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK (2014). "Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance". PLoS ONE. 9 (2): e88323. doi:10.1371/journal.pone.0088323. PMC 3914976. PMID 24505474.